{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T23:33:25Z","timestamp":1776814405478,"version":"3.51.2"},"reference-count":19,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2004,5,1]],"date-time":"2004-05-01T00:00:00Z","timestamp":1083369600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Il Farmaco"],"published-print":{"date-parts":[[2004,5]]},"DOI":"10.1016\/j.farmac.2004.01.016","type":"journal-article","created":{"date-parts":[[2004,4,3]],"date-time":"2004-04-03T10:19:28Z","timestamp":1080987568000},"page":"413-417","source":"Crossref","is-referenced-by-count":48,"title":["Synthesis and in vitro antileukemic activity of new 4-triazenopyrazole derivatives"],"prefix":"10.1016","volume":"59","author":[{"given":"Giuseppe","family":"Daidone","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Benedetta","family":"Maggio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Demetrio","family":"Raffa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Salvatore","family":"Plescia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Domenico","family":"Schillaci","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria","family":"Valeria Raimondi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.farmac.2004.01.016_BIB1","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/S0041-008X(71)80026-1","article-title":"Methylation of nucleic acid and urinary excretion of 14\u00a0C-labeled 7-methylguanine by rats and man after administration of 4(5)-(3,3-dimethyl-1-triazeno)-imidazole-5(4)-carboxamide","volume":"18","author":"Skiba","year":"1971","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.farmac.2004.01.016_BIB2","first-page":"465","article-title":"Metabolism of 5-(3,3-dimethyl-1-triazeno)imidazole-4-carboxamide (NSC-45388) in human and animal tumor tissue","volume":"56","author":"Mizuno","year":"1972","journal-title":"Cancer Chemoth. Rep. Part 1"},{"key":"10.1016\/j.farmac.2004.01.016_BIB3","first-page":"4884","article-title":"In vitro and in vivo methazolastone-induced DNA damage and repair in L-1210 leukemia sensitive and resistant to chloronitrosoureas","volume":"47","author":"Catapano","year":"1987","journal-title":"Cancer Res."},{"key":"10.1016\/j.farmac.2004.01.016_BIB4","doi-asserted-by":"crossref","first-page":"94","DOI":"10.3109\/13547509609088676","article-title":"N7-methylguanine and O6-methylguanine levels in DNA of white blood cells from cancer patients treated with dacarbazine","volume":"1","author":"Van Delft","year":"1996","journal-title":"Bioomarkers"},{"key":"10.1016\/j.farmac.2004.01.016_BIB5","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/0024-3205(69)90448-2","article-title":"Elevated urinary excretion of 4-aminoimidazole-5-carboxamide in patients after intravenous injection of 4-(3,3-dimethyl-1-triazeno)imidazole-5-carboxamide","volume":"8","author":"Housholder","year":"1969","journal-title":"Life Science"},{"key":"10.1016\/j.farmac.2004.01.016_BIB6","first-page":"386","article-title":"Disposition of 5-(3,3-dimethyl-1-triazeno)imidazole-4-carboxamide, a new antitumor agent","volume":"179","author":"Housholder","year":"1971","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.farmac.2004.01.016_BIB7","first-page":"159","article-title":"Triazenes","author":"Vaugham","year":"1990"},{"key":"10.1016\/j.farmac.2004.01.016_BIB8","first-page":"163","article-title":"Triazenylimidazoles, other triazenes, and imidazo[5,1-d]-1,2,3,5-tetrazin-4(3H)-ones","author":"Fulmer Shealy","year":"1955"},{"key":"10.1016\/j.farmac.2004.01.016_BIB9","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/0223-5234(96)85884-3","article-title":"Synthesis of 1-(isoxazol-3-yl)triazene derivatives. Antimetastatic activity of 3,3-dimethyl-1-(5-methylisoxazol-3-yl)triazene","volume":"31","author":"Tontini","year":"1996","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.farmac.2004.01.016_BIB10","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/S0223-5234(99)80085-3","article-title":"2-Triazenopyrroles: synthesis and biological activity","volume":"34","author":"Diana","year":"1999","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.farmac.2004.01.016_BIB11","first-page":"889","volume":"29","author":"Cirrincione","year":"1994"},{"key":"10.1016\/j.farmac.2004.01.016_BIB12","first-page":"2127","article-title":"Synthesis and antiproliferative activity of triazenothiophenes","volume":"19","author":"Diana","year":"1999","journal-title":"Anticancer Res."},{"key":"10.1016\/j.farmac.2004.01.016_BIB13","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1021\/jm00009a010","article-title":"Antitumor imidazotetrazines. 32. Synthesis of novel imidazotetrazinones and related bicyclic heterocycles to probe the mode of action of the antitumor drug Temozolomide","volume":"38","author":"Clark","year":"1995","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.farmac.2004.01.016_BIB14","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/S0223-5234(98)80004-4","article-title":"Antimicrobial and antineoplastic activities of new 4-diazopyrazole derivatives","volume":"33","author":"Daidone","year":"1998","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.farmac.2004.01.016_BIB15","first-page":"557","article-title":"Synthesis and antineoplastic activity of new 4-diazopyrazole","volume":"52","author":"Daidone","year":"1997","journal-title":"Il Farmaco"},{"key":"10.1016\/j.farmac.2004.01.016_BIB16","first-page":"251","article-title":"Synthesis of new 3-(3-phenyl-isoxazol-5-yl) or 3-[(3-phenyl-isoxazol-5-yl)amido]substituted 4(3H)-quinazolinone derivatives with antineoplastic activity","volume":"54","author":"Raffa","year":"1999","journal-title":"Die Pharmazie"},{"key":"10.1016\/j.farmac.2004.01.016_BIB17","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1002\/(SICI)1521-4184(19999)332:9<317::AID-ARDP317>3.0.CO;2-R","article-title":"Synthesis and antiproliferative activity of novel 3-(indazol-3-yl)-quinazolin-4(3H)-one and 3-(indazol-3-yl)-benzotriazin-4(3H)-one derivatives","volume":"332","author":"Raffa","year":"1999","journal-title":"Arch. Pharm. Med. Chem."},{"key":"10.1016\/j.farmac.2004.01.016_BIB18","doi-asserted-by":"crossref","first-page":"3377","DOI":"10.1021\/jm00096a013","article-title":"Antitumor imidazotetrazines. 25. Crystal structure of carbamoyl-3-methylimidazo[5,1-d]-1,2,3,5-tetrazin-4(3H)-one (\u00a0Temozolomide\u00a0) and structural comparisons with the related drugs Mitozolomide and DTIC","volume":"35","author":"Lowe","year":"1992","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.farmac.2004.01.016_BIB19","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1021\/jm00083a017","article-title":"Pyrazole-related nucleoside. Synthesis and antiviral\/antitumor activity of some substituted pyrazole and pyrazole[4,3-d]-1,2,3-triazin-4-one nucleosides","volume":"35","author":"Manfredini","year":"1992","journal-title":"J. Med. Chem."}],"container-title":["Il Farmaco"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014827X04000527?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014827X04000527?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,2,14]],"date-time":"2019-02-14T07:57:32Z","timestamp":1550131052000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014827X04000527"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,5]]},"references-count":19,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2004,5]]}},"alternative-id":["S0014827X04000527"],"URL":"https:\/\/doi.org\/10.1016\/j.farmac.2004.01.016","relation":{},"ISSN":["0014-827X"],"issn-type":[{"value":"0014-827X","type":"print"}],"subject":[],"published":{"date-parts":[[2004,5]]}}}